Urgency as an Endpoint in Irritable Bowel Syndrome

BACKGROUND: The choice of endpoints is crucial for proper evaluation of agents in clinical trials of irritable bowel syndrome (IBS). In a recently published draft guidance for IBS from the United States Food and Drug Administration (FDA), urgency was not considered an appropriate primary endpoint. T...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Gastroenterology Res
Päätekijät: Mangel, Allen W., Wang, Jianmin, Sherrill, Beth, Gnanasakthy, Ari, Ervin, Claire, Fehnel, Sheri E.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Elmer Press 2011
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5139794/
https://ncbi.nlm.nih.gov/pubmed/27957006
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4021/gr283e
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia